Corcept Therapeutics
CORT
#3687
Rank
S$4.76 B
Marketcap
S$45.22
Share price
-1.21%
Change (1 day)
-46.65%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of September 2025 : S$8.03 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is S$8.03 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$9.42 M4627.52%
2023-12-31S$0.19 M-86.99%
2022-12-31S$1.53 M115.48%
2021-12-31S$0.71 M-78.93%
2020-12-31S$3.37 M-27.67%
2019-12-31S$4.66 M
2018-12-31N/A
2016-12-31S$21.22 M0.26%
2015-12-31S$21.16 M70%
2014-12-31S$12.45 M71.14%
2013-12-31S$7.27 M124.53%
2012-12-31S$3.24 M
2010-12-31N/A-100%
2009-12-31S$0 M-63.19%
2008-12-31S$0.02 M-45.17%
2007-12-31S$0.04 M-35.2%
2006-12-31S$0.06 M-28.37%
2005-12-31S$0.08 M
2003-12-31S$0.88 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$60.58 B 753,800.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$44.71 B 556,301.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$76.90 B 956,930.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$53.72 B 668,396.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$52.29 B 650,639.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$59.58 B 741,312.39%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$0.15 B 1,785.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.38 B 4,725.34%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.76 B 9,403.63%๐Ÿ‡บ๐Ÿ‡ธ USA